Question 1

What is Curium Pharma?

Accepted Answer

Curium Pharma is a Entity.

Question 2

How often does Curium Pharma appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 6 articles.

Question 3

When was Curium Pharma first tracked by Ergen?

Accepted Answer

First tracked on Jun 11, 2026.

Question 4

When was Curium Pharma last mentioned in news?

Accepted Answer

Last active on Jun 11, 2026.

Question 5

What is Curium Pharma's current news sentiment?

Accepted Answer

Aggregate sentiment score: 70 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Curium Pharma in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving Curium Pharma?

Accepted Answer

Curium, PeptiDream complete prostate cancer trial (Jun 11, 2026, 6 articles).

Question 8

How did the "Curium, PeptiDream complete prostate cancer trial" event impact Curium Pharma?

Accepted Answer

Curium Pharma, a global radiopharmaceutical company, is a key partner in the clinical development of 64Cu-PSMA-I&T and 177Lu-PSMA-I&T, leading global development and supporting technology transfer to Japan. The completion of patient dosing in the Phase 2 trial in Japan is a significant milestone for its mission to expand access to radiopharmaceuticals in Asia.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.